Turn Therapeutics (TTRX) Shares Issued (2024 - 2025)
Turn Therapeutics' quarterly Shares Issued came in at $3.2 million in Q4 2025, down 95.76% year-on-year from $75.0 million in Q4 2024, and up 959.23% quarter-over-quarter from $300000.0 in Q1 2025.
Turn Therapeutics has reported Shares Issued for 2 years, with the latest figure at $3.2 million in Q4 2025.
- For the quarter ending Q4 2025, Shares Issued fell 95.76% year-over-year to $3.2 million; the trailing twelve-month figure through Mar 2025 stood at $300000.0 (changed N/A YoY), and the FY2025 full-year result was $6.9 million, up 500.45% from the prior year.
- Shares Issued for Q4 2025 stood at $3.2 million, up from $300000.0 in the prior quarter.
- The five-year high for Shares Issued was $75.0 million in Q4 2024, with the low at $300000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Turn Therapeutics | 188.06 Mn | 188.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.18 Mn |
| Dec 31, 2025 | 3.18 Mn |
| Mar 31, 2025 | 300,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Dec 31, 2024 | 75.00 Mn |
| Dec 31, 2024 | 75.00 Mn |